Catalyst Wire Dossier Catalyst Wire Dossier

Investigational oral drug for narcolepsy

· Otsuka Pharmaceutical Development & Commercialization, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Investigational oral drug for narcolepsy, covering 2024-06-26 to 2024-06-26. Get the full timeline:

Most recent: Clinical Trial Update: This is a Study to Determine the Effect of Multiple Doses of an Investigational Drug, Taken by Mouth, in People With Narcolepsy-cataplexy. Accepting Both Males and Females Ages of 18 Years to 55 Years. This Study Will be Conducted in the US and Will Require Approximately 13 Weeks Participation. [Phase 1]

See pricing